Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Cultivating. Innovating. Operating: Discovering the Science of CBD

Sire Bioscience Inc’s ( CSE.SIRE , OTC: BLLXF , Forum ) business model is based on their ability to engage in the investment, production, and sale of hemp for CBD extraction. That’s the desirable scalable endgame for any cannabis company....
Dave Jackson | May 13, 2020 |

Powering the Green Energy Revolution: Discovering New Nickel Deposits in Canada

Here’s a green energy, electric vehicle metals play worth getting to know… now. Metal Energy Corp. ( TSX-V.MERG , Forum ) is a high-potential exploration & development company focussed on high-quality nickel projects in Canada’s prolific ...
Dave Jackson | January 24, 2022 |

This stealth rally is about to explode into a huge bull market

It was a "stealth" rally... Over the first couple months of 2010, the U.S. stock market hovered around breakeven. Investors were too busy worrying about Greece's debt crisis, fourth-quarter earnings, and health care reform to notice what was happening over in my c...
Dr. George Huang | October 28, 2012 |

Kiniksa Pharma Awarded FDA Breakthrough Therapy Status for Pericarditis Treatment Drug

Shares of Kiniksa Pharmaceuticals opened nearly 30% higher today after the firm reported that the FDA granted Breakthrough Therapy designation for Rilonacept for the treatment of recurrent pericarditis. This morning, Hamilton, Bermuda based biopharmaceutical company ...
Streetwise Reports | November 21, 2019 |

ATEX Resources: A copper and gold explorer with a strategic advantage in Latin America

ATEX Resources’ management team has a history of discovering major mineral deposits in South America, including the La Fortuna copper-gold deposit and the Pascua, Volcan and Maricunga gold deposits in Chile, to name a few. Most recently, the company co...
Brieanna McCutcheon | November 2, 2022 |

Recent Bonanza-Grade Gold Intercepts Mean These Companies Could Explode Higher Very Soon

Hitting bonanza grades during a gold bull means good things for investors. GoldStockBull subscribers know that gold mining stocks have done quite well in recent months. But companies that have recently found bonanza-grade gold have upside potential above and be...
Streetwise Reports | August 7, 2019 |

Site Visit Shows Mining Company Now in Development Phase

Project highlights gleaned during the trip are recounted in a BMO Capital Markets report. In a May 21 research note, BMO Capital Markets analyst Andrew Mikitchook reported that during a recent multisite tour, Ivanhoe Mines Ltd.'s (IVN:TSX; IVPAF:OTCQX) "wo...
Streetwise Reports | May 27, 2019 |

Galapagos Agrees to $3.95 Billion, 10-Year Licensing Deal Plus $1.1 Billion Investment from Gilead

Galapagos announced that Gilead Sciences has agreed to pay $3.95 billion for a 10-year partnership and licensing deal and will invest an additional $1.1 billion in newly issued shares of the company. Galapagos NV (GLPG:NASDAQ; GLPG:BSE) ADR shares opened up over 1...
Streetwise Reports | July 16, 2019 |

Amgen Shares React Favorably to Enbrel Patent Case Victory

Amgen shares are trading 5–6% higher today on news that the company has won its Enbrel (etanercept) patent court case. On Friday, August 9, 2019, Amgen Inc. (AMGN:NASDAQ) announced that it had won its Enbrel patent case. The company advised that the U.S. District C...
Streetwise Reports | August 14, 2019 |

Biogen Shares Rebound Strongly on Updated Phase 3 Alzheimer's Data and Q3 Earnings

Shares of Biogen Inc. opened nearly 39% higher today after the firm announced plans to submit a Biologics License Application to the FDA in early 2020 for its Alzheimer's drug aducanumab based on new analysis of larger datasets from two phase 3 studies. The company also anno...
Streetwise Reports | October 23, 2019 |
1 2 3 4 5 6 7 8